Cargando…

Therapy‐related acute myeloid leukemia after chemotherapy in extensive disease‐small cell lung cancer

We experienced therapy‐related acute myeloid leukemia (t‐AML) in a patient with extensive disease‐small cell lung cancer (ED‐SCLC). This case is rare and has educational message because ED‐SCLC has a poor prognosis and often cannot survive until developing therapy related hematological malignancy. F...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueda, Naoko, Fujita, Kohei, Okuno, Yoshiaki, Nakatani, Koichi, Mio, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332741/
https://www.ncbi.nlm.nih.gov/pubmed/30656018
http://dx.doi.org/10.1002/ccr3.1931
_version_ 1783387420890234880
author Ueda, Naoko
Fujita, Kohei
Okuno, Yoshiaki
Nakatani, Koichi
Mio, Tadashi
author_facet Ueda, Naoko
Fujita, Kohei
Okuno, Yoshiaki
Nakatani, Koichi
Mio, Tadashi
author_sort Ueda, Naoko
collection PubMed
description We experienced therapy‐related acute myeloid leukemia (t‐AML) in a patient with extensive disease‐small cell lung cancer (ED‐SCLC). This case is rare and has educational message because ED‐SCLC has a poor prognosis and often cannot survive until developing therapy related hematological malignancy. Furthermore this case had unique chromosomal abnormalities. With recent advances in chemotherapy and radiotherapy, the prognosis of lung cancer has improved, while t‐AML has been increasing in frequency.
format Online
Article
Text
id pubmed-6332741
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-63327412019-01-17 Therapy‐related acute myeloid leukemia after chemotherapy in extensive disease‐small cell lung cancer Ueda, Naoko Fujita, Kohei Okuno, Yoshiaki Nakatani, Koichi Mio, Tadashi Clin Case Rep Case Reports We experienced therapy‐related acute myeloid leukemia (t‐AML) in a patient with extensive disease‐small cell lung cancer (ED‐SCLC). This case is rare and has educational message because ED‐SCLC has a poor prognosis and often cannot survive until developing therapy related hematological malignancy. Furthermore this case had unique chromosomal abnormalities. With recent advances in chemotherapy and radiotherapy, the prognosis of lung cancer has improved, while t‐AML has been increasing in frequency. John Wiley and Sons Inc. 2018-11-19 /pmc/articles/PMC6332741/ /pubmed/30656018 http://dx.doi.org/10.1002/ccr3.1931 Text en © 2018 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Reports
Ueda, Naoko
Fujita, Kohei
Okuno, Yoshiaki
Nakatani, Koichi
Mio, Tadashi
Therapy‐related acute myeloid leukemia after chemotherapy in extensive disease‐small cell lung cancer
title Therapy‐related acute myeloid leukemia after chemotherapy in extensive disease‐small cell lung cancer
title_full Therapy‐related acute myeloid leukemia after chemotherapy in extensive disease‐small cell lung cancer
title_fullStr Therapy‐related acute myeloid leukemia after chemotherapy in extensive disease‐small cell lung cancer
title_full_unstemmed Therapy‐related acute myeloid leukemia after chemotherapy in extensive disease‐small cell lung cancer
title_short Therapy‐related acute myeloid leukemia after chemotherapy in extensive disease‐small cell lung cancer
title_sort therapy‐related acute myeloid leukemia after chemotherapy in extensive disease‐small cell lung cancer
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332741/
https://www.ncbi.nlm.nih.gov/pubmed/30656018
http://dx.doi.org/10.1002/ccr3.1931
work_keys_str_mv AT uedanaoko therapyrelatedacutemyeloidleukemiaafterchemotherapyinextensivediseasesmallcelllungcancer
AT fujitakohei therapyrelatedacutemyeloidleukemiaafterchemotherapyinextensivediseasesmallcelllungcancer
AT okunoyoshiaki therapyrelatedacutemyeloidleukemiaafterchemotherapyinextensivediseasesmallcelllungcancer
AT nakatanikoichi therapyrelatedacutemyeloidleukemiaafterchemotherapyinextensivediseasesmallcelllungcancer
AT miotadashi therapyrelatedacutemyeloidleukemiaafterchemotherapyinextensivediseasesmallcelllungcancer